These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5134838)

  • 61. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fibrinogen-fibrin conversion. The mechanism of fibrin-polymer formation in solution.
    Smith GF
    Biochem J; 1980 Jan; 185(1):1-11. PubMed ID: 7378042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The procoagulant effect of thrombin on fibrin(ogen)-bound platelets.
    Sanders MW; Nieuwenhuys CM; Feijge MA; Rook M; Béguin S; Heemskerk JW
    Haemostasis; 1998; 28(6):289-300. PubMed ID: 10461011
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Fibrinogen: biophysical, biochemical and biological properties].
    Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(1):1-30. PubMed ID: 4118778
    [No Abstract]   [Full Text] [Related]  

  • 65. Soluble fibrin causes an acquired platelet glycoprotein VI signaling defect: implications for coagulopathy.
    Lee MY; Verni CC; Herbig BA; Diamond SL
    J Thromb Haemost; 2017 Dec; 15(12):2396-2407. PubMed ID: 28981200
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The interactions of fibrinogen and dextrans with erythrocytes.
    Rampling M; Sirs JA
    J Physiol; 1972 May; 223(1):199-212. PubMed ID: 5046146
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Soluble crosslinked fibrin(ogen) polymers.
    Selmayr E; Müller-Berghaus G
    Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 69. INFLUENCE OF FIBRINOGEN ON FLOW PROPERTIES OF ERYTHROCYTE SUSPENSIONS.
    WELLS RE; GAWRONSKI TH; COX PJ; PERERA RD
    Am J Physiol; 1964 Nov; 207():1035-40. PubMed ID: 14237445
    [No Abstract]   [Full Text] [Related]  

  • 70. Nonclottable fibrin obtained from partially reduced fibrinogen: characterization and tissue plasminogen activator stimulation.
    Procyk R; Medved L; Engelke KJ; Kudryk B; Blombäck B
    Biochemistry; 1992 Mar; 31(8):2273-8. PubMed ID: 1540582
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pulmonary vasoconstrictor response to soluble fibrin in isolated lungs: possible role of thromboxane generation.
    Seeger W; Neuhof H; Hall J; Roka L
    Circ Res; 1988 Apr; 62(4):651-9. PubMed ID: 3349571
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors.
    Fusman G; Mardi T; Justo D; Rozenblat M; Rotstein R; Zeltser D; Rubinstein A; Koffler M; Shabtai E; Berliner S; Shapira I
    Am J Cardiol; 2002 Sep; 90(5):561-3. PubMed ID: 12208427
    [No Abstract]   [Full Text] [Related]  

  • 74. Retention of thrombin by polytetrafluoroethylene: influence on the adsorption of fibrinogen/fibrin.
    Schlosser E; Simler R; Hörmann H
    Biomaterials; 1993 Apr; 14(5):365-70. PubMed ID: 8507780
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and on fragment D from fibrinogen, non cross-linked or cross-linked fibrin.
    Bini A; Semeraro N; Collen D
    Thromb Res; 1978 Sep; 13(3):443-51. PubMed ID: 741438
    [No Abstract]   [Full Text] [Related]  

  • 76. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Fibrinogen B (soluble fibrinogen), its nature and methods of determination].
    Belitser VA
    Lab Delo; 1980; (9):529-32. PubMed ID: 6157920
    [No Abstract]   [Full Text] [Related]  

  • 78. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W; Delvos U; Müller-Berghaus G
    Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Involvement of fibrinogen specific binding in erythrocyte aggregation.
    Lominadze D; Dean WL
    FEBS Lett; 2002 Apr; 517(1-3):41-4. PubMed ID: 12062406
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Carbohydrate-binding activities of coagulation factors fibrinogen and fibrin.
    Date K; Ohyama M; Ogawa H
    Glycoconj J; 2015 Aug; 32(6):385-92. PubMed ID: 26050259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.